[
  {
    "ts": null,
    "headline": "Viking Therapeutics: The Turning Point Is Not Here Yet",
    "summary": "Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma remains risky.",
    "url": "https://finnhub.io/api/news?id=13352d11da720b6f820b3d891efe5ba459d5c223aa5daaf2ec4bd3b9bb12ead0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737383698,
      "headline": "Viking Therapeutics: The Turning Point Is Not Here Yet",
      "id": 132431719,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2025836701/image_2025836701.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Viking Therapeutics investors face challenges as stock plummets, cash runway helps but betting on early stage biopharma remains risky.",
      "url": "https://finnhub.io/api/news?id=13352d11da720b6f820b3d891efe5ba459d5c223aa5daaf2ec4bd3b9bb12ead0"
    }
  },
  {
    "ts": null,
    "headline": "Carillon ClariVest Capital Appreciation Fund Q4 2024 Commentary",
    "summary": "At the start of the quarter, Carillon ClariVest Capital Appreciation Fund vs. Russell 1000 Growth Index, was most overweight the healthcare and financials sectors.",
    "url": "https://finnhub.io/api/news?id=54cf828d9caeaafcb426d9422ac96510c78190fca07684df97dbf1bdbb80c73c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737373020,
      "headline": "Carillon ClariVest Capital Appreciation Fund Q4 2024 Commentary",
      "id": 132431001,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1089284390/image_1089284390.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "At the start of the quarter, Carillon ClariVest Capital Appreciation Fund vs. Russell 1000 Growth Index, was most overweight the healthcare and financials sectors.",
      "url": "https://finnhub.io/api/news?id=54cf828d9caeaafcb426d9422ac96510c78190fca07684df97dbf1bdbb80c73c"
    }
  },
  {
    "ts": null,
    "headline": "ClearBridge Appreciation ESG Strategy Q4 2024 Commentary",
    "summary": "The ClearBridge Appreciation ESG Strategy outperformed the benchmark S&P 500 Index in the fourth quarter of 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=d0b43507d72a706c01efba5d99d3bb9d5b02d85ccda8e897b48dce6f06529f28",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737359700,
      "headline": "ClearBridge Appreciation ESG Strategy Q4 2024 Commentary",
      "id": 132429975,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1356723961/image_1356723961.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "The ClearBridge Appreciation ESG Strategy outperformed the benchmark S&P 500 Index in the fourth quarter of 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=d0b43507d72a706c01efba5d99d3bb9d5b02d85ccda8e897b48dce6f06529f28"
    }
  },
  {
    "ts": null,
    "headline": "IYH: Healthcare Dashboard For January",
    "summary": "iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.",
    "url": "https://finnhub.io/api/news?id=86abfb300be5fe18fd5f0ffd4e4f143d62a99946668de83db5584543560aa5e1",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737351767,
      "headline": "IYH: Healthcare Dashboard For January",
      "id": 132429429,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2154850841/image_2154850841.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.",
      "url": "https://finnhub.io/api/news?id=86abfb300be5fe18fd5f0ffd4e4f143d62a99946668de83db5584543560aa5e1"
    }
  }
]